DrugPatentWatch Database Preview

Details for Patent: 6,958,161

« Back to Dashboard

Which drugs does patent 6,958,161 protect, and when does it expire?

Patent 6,958,161 protects DORYX and DORYX MPC and is included in one NDA.

Summary for Patent: 6,958,161

Title:	Modified release coated drug preparation
Abstract:	A modified release preparation having one or more coated core elements, each core element including an active ingredient and having a modified release coating, wherein a stabilising coat is provided between each core element and its modified release coating so that, upon in vitro dissolution testing, the amount of active ingredient released at any time on a post-storage dissolution profile is within 40 percentage points of the amount of active ingredient released at any time on a pre-storage dissolution profile.
Inventor(s):	Hayes; David (Rostrevor, AU), LoPore; Angelo (Magill, AU), Lukas; Stefan (Manningham, AU), Quinn; Eugene (Prospect, AU)
Assignee:	F H Faulding & Co Limited (Underdale, AU)
Application Number:	10/120,376
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,958,161
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 6,958,161
Patent Claim Types: see list of patent claims	Formulation; Compound; Use; Dosage form;

Drugs Protected by US Patent 6,958,161

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Mayne Pharma	DORYX	doxycycline hyclate	TABLET, DELAYED RELEASE;ORAL	050795-006	Dec 19, 2014	AB	RX	Yes	No			Y			TO TREAT OR PREVENT INFECTIONS CAUSED BY SUSCEPTIBLE BACTERIA USING DELAYED-RELEASE TABLETS CONSISTING OF DOXYCYCLINE HYCLATE COATED PELLETS IN A TABLET
Mayne Pharma	DORYX	doxycycline hyclate	TABLET, DELAYED RELEASE;ORAL	050795-001	May 6, 2005	AB	RX	Yes	No			Y			TO TREAT OR PREVENT INFECTIONS CAUSED BY SUSCEPTIBLE BACTERIA USING DELAYED-RELEASE TABLETS CONSISTING OF DOXYCYCLINE HYCLATE COATED PELLETS IN A TABLET
Mayne Pharma	DORYX	doxycycline hyclate	TABLET, DELAYED RELEASE;ORAL	050795-004	Apr 11, 2013		DISCN	Yes	No			Y			TO TREAT OR PREVENT INFECTIONS CAUSED BY SUSCEPTIBLE BACTERIA USING DELAYED-RELEASE TABLETS CONSISTING OF DOXYCYCLINE HYCLATE COATED PELLETS IN A TABLET
Mayne Pharma	DORYX	doxycycline hyclate	TABLET, DELAYED RELEASE;ORAL	050795-002	May 6, 2005	AB	RX	Yes	No			Y			TO TREAT OR PREVENT INFECTIONS CAUSED BY SUSCEPTIBLE BACTERIA USING DELAYED-RELEASE TABLETS CONSISTING OF DOXYCYCLINE HYCLATE COATED PELLETS IN A TABLET
Mayne Pharma	DORYX	doxycycline hyclate	TABLET, DELAYED RELEASE;ORAL	050795-003	Jun 20, 2008	AB	RX	Yes	No			Y			TO TREAT OR PREVENT INFECTIONS CAUSED BY SUSCEPTIBLE BACTERIA USING DELAYED-RELEASE TABLETS CONSISTING OF DOXYCYCLINE HYCLATE COATED PELLETS IN A TABLET